Global differences in patient characteristics, case management and outcomes in intracerebral hemorrhage: The factor seven for acute hemorrhagic stroke (FAST) trial

Cerebrovascular Diseases

Volumn 28, Issue 1, 2009, Pages 55-64

  Christensen, Michael C ^a   Broderick, Joseph ^b   Vincent, Catherine ^a   Morris, Stephen ^c   Steiner, Thorsten ^d  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF CINCINNATI   (United States)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Case management; Disability; International variation; Intracerebral hemorrhage; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 7; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERTONIC SOLUTION; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MANNITOL; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE FLUCTUATION; BRAIN EDEMA; BRAIN HEMORRHAGE; CASE MANAGEMENT; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFECTION; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

AGE FACTORS; AGED; CASE MANAGEMENT; CEREBRAL HEMORRHAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL COOPERATION; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 66049144500     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000219298     Document Type: Article

References (28)

1. Wolfe CDA, Tilling K, Beech R, Rudd AG: Variations in case fatality and dependency from stroke in western and central Europe. Stroke 1999;30:350-356.
2. Gray LJ, Sprigg N, Bath PM, Sorensen P, Lindenstrom E, Boysen G, De Deyn PP, Friis P, Leys D, Marttila R, Olsson JE, O'Neill D, Ringelstein B, van der Sande JJ, Turpie AG: Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST). J Neurol Neurosurg Psychiatry 2006;77:327-333.
3. Beech R, Ratcliffe M, Tilling K, Wolfe C: Hospital services for stroke care: a European perspective. Stroke 1996;27:1958-1964.
4. Weir NU, Sandercock PAG, Lewis SC, Si- gnorini DF, Warlow CP: Variations between countries in outcome after stroke in the International Stroke Trial (IST). Stroke 2001; 32:1370-1377.
5. Mitchell JB, Ballard DJ, Whisnant JP, Ammering CJ, Samsa GP, Matchar DB: What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke 1996;27:1937-1943.
6. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO: Ischemic stroke: outcomes, patient mix, and practice variation for neurologists and generalists in a community. Neurology 1998; 50: 1669-1678.
7. Webb DJ, Fayad PB, Al Bakri E, Schneck MJ,Russell-McCaleb K, Wilbur C, Thomas A, Twohill J, Leifer D, Brass LM: Five-year effects of a specialized team on in-patient stroke care. Stroke 1997;28:270.
8. Bowen J, Yaste C: Effect of a stroke protocol on hospital costs of stroke patients. Neurology 1994;44:1961-1964.
9. Wentworth DA, Atkinson RP: Implementation of an acute stroke program decreases hospitalization costs and length of stay.Stroke 1996; 27:1040-1043.
10. Leys D, Ringelstein EB, Kaste M, Hacke W:Facilities available in European hospitals treating stroke patients. Stroke 2007; 38:2985-2991.
11. Goldstein LB, Hey LA, Laney R: North Carolina Stroke Prevention and Treatment Facilities Survey: statewide availability of programs and services. Stroke 2000;31:66-70.
12. Mayer S, Brun NC, Begtrup K, Broderick J, Davis S, Diringer M, Skolnick BE, Steiner T: Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127- 2137.
13. Broderick JP, Adams HP Jr, Barsan W, et al: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999; 30: 905-915.
14. Broderick J, Connolly S, Feldmann E, et al: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update. Stroke 2007;38:2001-2023.
15. European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee: Recommendations for the management of intracranial haemorrhage. 1. Spontaneous intracerebral haemorrhage. Cerebrovasc Dis 2006; 22: 294-316.
16. Saver JL, Eckstein M, Stratton S, Hamilton S, Conwit R, Liebeskind D, Sung G, Starkman S; FAST-MAG Investigators: The Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Phase 3 Clinical Trial. Ongoing Clinical Trial Poster Session Abstract Book, Int Stroke Conf 2008, New Orleans, February 20, 2008.
17. Saposnik G, Jeerakathil T, Selchen D, Baibergenova A, Hachinski V, Kapral MK: Socioeconomic status, hospital volume, and stroke fatality in Canada. Stroke 2008; 39:3360-3366.
18. Cheng E, Vickrey B: Is there a relationship between prestroke social isolation and outcomes following stroke? Nat Clin Pract Neurol 2006;2:16-17.
19. Kromhout D, Bloemberg B, Feskens E, Menotti A, Nissinen A; Seven Countries Study Group: Saturated fat, vitamin C and smoking predict long-term population all- cause mortality rates in the Seven Countries Study. Int J Epidemiol 2000;29:260-265.
20. Zatonski WA, Willett W: Changes in dietary fat and declining coronary heart disease in Poland: a population-based study. BMJ 2005;331: 187-188.
21. Woo D, Sauerbeck LR, Kissela BM, et al: Genetic and environmental risk factors for in- tracerebral hemorrhage: preliminary results of a population-based study. Stroke 2002;33:1190-1196.
22. Juettler E, Steiner T: Treatment and prevention of intracerebral hemorrhage: comparison of EUSI and AHA/ASA recommendations. Exp Rev Neurother 2006;7: 1401-1416.
23. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G: Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993; 24: 987-993.
24. Steiner T, Diringer MN, Schneider D, Mayer SA, Begtrup K, Broderick J, Skolnick BE, Davis SM: Dynamics of intraventricular hemorrhage in patients with spontaneous intra- cerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII. Neu-rosurgery 2006; 59: 767-773.
25. Wong KS: Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: a prospective hospital-based study in Asia. Asian Acute Stroke Advisory Panel. Stroke 1999; 30: 2326-2330.
26. Diringer MN, Edwards DF: Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 2001;29: 635-640.
27. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559.
28. Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB: Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke2008;39: 497-502.